AGP Executive Report
Last update: 7 hours agoEU-EEA Trade & Tariffs: Brazil has formally incorporated the Mercosur–EFTA Free Trade Agreement, with preferential tariffs for Switzerland and Liechtenstein set to apply once both sides complete internal steps (Brazil from Oct 1; Norway from Nov 1). Pharma & Trade Policy: The US Commerce Department clarified which specialty drugs and ingredients can get zero tariffs ahead of a Sept 29 deadline, listing eligible products and countries including Liechtenstein. Biotech Milestone: The European Commission granted marketing authorisation for NEZGLYAL® (leriglitazone) for childhood cerebral adrenoleukodystrophy (cALD), the first pharmacological treatment approved in the EU, with first launches expected in Germany. Banking & Ownership: Bendura Bank marked ten years under Hong Kong’s Citychamp Watch & Jewellery Group, highlighting continuity in Liechtenstein’s financial sector. Cross-Border Business Climate: Chinese automakers kept gaining ground in Europe in August, with BYD registrations more than doubling across EU/UK/Iceland/Liechtenstein/Norway/Switzerland—raising competitive pressure for local brands. Business-Adjacent Travel/Visas: China published an updated list of 50 countries eligible for 30-day visa-free entry, including Liechtenstein.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
